UF investigators studied the feasibility of the immunoarray platform to screen microparticle- encapsulated adjuvant combinations for the development of improved and personalized vaccines.
UF investigators published a paper on dendritic cell activation in the Journal of Materials Chemistry B.
Two recent publications explored different methods of delivering a vaccine for type 1 diabetes, both of which prevented 40 percent of mice from developing the disease.
Learn about the latest drug-delivery system developed by University of Florida researches that holds the promise for ways to treat and ultimately prevent persons from developing Type 1 Diabetes. The joint effort is bringing research closer to a cure.
